Spero Therapeutics, Inc.
SPRO
Revenue
0.00
0.000.00%
3 Months ChangeAssets
54.17M
▼-7.95M▼-12.80%
3 Months ChangeLiabilities
27.68M
▼-1.62M▼-5.51%
3 Months ChangeFree Cash Flow
-23.41M
▼-12.40M▼-112.70%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-30
Form 8-K
ID: 0001193125-26-032004
2025-12-19
Form 8-K
ID: 0001193125-25-325821
2025-11-13
Form 8-K
ID: 0001193125-25-280518
2025-11-13
Form 10-Q
ID: 0001193125-25-280174
2025-08-12
Form 10-Q
ID: 0000950170-25-107388
2025-08-12
Form 8-K
ID: 0001193125-25-178970
2025-06-18
Form 8-K
ID: 0001193125-25-142807
2025-05-28
Form 8-K
ID: 0001193125-25-128680
2025-05-13
Form 8-K
ID: 0001193125-25-118882
2025-05-13
Form 10-Q
ID: 0000950170-25-070380